The dose due to short-lived thoron decay products was calculated using a dosimetric approach. The calculations were based on a computer program LUDEP, which implements the ICRP 66 respiratory tract model. The dose per equilibrium equivalent concentration for thoron (EETC) was calculated with respect to: (1) equivalent dose to each region of the lung tissues (bronchial, bronchiolar and alveolar), (2) weighted equivalent dose to other organs than the lungs, and (3) effective dose.
The calculations indicated that (1) the most exposed region of the lung tissues was the bronchial for unattached fraction and the bronchiolar for attached fraction, (2) the contribution to effective dose mostly resulted from the lungs and (3) the effective dose per EETC was about four times larger than the effective dose per equilibrium equivalent concentration for radon (EERC).
The calculated dose conversion factors were applied to comparative dosimetry for some thoron-enhanced areas where EERC and EETC were measured. In the case of a spa in Japan, the dose from thoron decay products was larger than the dose from radon decay products.
